This page is part of the FHIR Specification (v4.1.0: Release 4B Ballot #1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3
Pharmacy Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Encounter, Patient, Practitioner |
Raw JSON (canonical form + also see JSON Format Specification)
Liquid Medication - Phenytoin with link to prior prescription
{ "resourceType": "MedicationRequest", "id": "medrx0312", "text": { "status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><p><b>identifier</b>: id: 12345689 (OFFICIAL)</p><p><b>status</b>: active</p><p><b>intent</b>: order</p><p><b>medication</b>: <span>Phenytoin 25mg/ml oral suspension</span></p><p><b>subject</b>: <a>Donald Duck. Generated Summary: Medical record number: 654321 (USUAL); active; Duck Donald (OFFICIAL); gender: male</a></p><p><b>authoredOn</b>: 2015-01-15</p><p><b>requester</b>: <a>Patrick Pump. Generated Summary: id: 874635264 (OFFICIAL), id: 567IUI51C154 (USUAL); Simone Heps (OFFICIAL); Phone: 020556936, S.M.Heps@bmc.nl, Fax: 0205669283; gender: female; birthDate: 1971-11-07</a></p><p><b>reasonCode</b>: <span>Status epilepticus (disorder)</span></p><p><b>note</b>: Patient should be counselled to ensure good dental hygiene</p><h3>DosageInstructions</h3><table><tr><td>-</td></tr><tr><td>*</td></tr></table><blockquote><p><b>dispenseRequest</b></p><p><b>validityPeriod</b>: 2015-01-15 --> 2016-01-15</p><p><b>numberOfRepeatsAllowed</b>: 3</p><p><b>quantity</b>: 360 mL</p><h3>ExpectedSupplyDurations</h3><table><tr><td>-</td></tr><tr><td>*</td></tr></table></blockquote><h3>Substitutions</h3><table><tr><td>-</td><td><b>Allowed[x]</b></td><td><b>Reason</b></td></tr><tr><td>*</td><td>true</td><td><span>Continuing therapy</span></td></tr></table><p><b>priorPrescription</b>: <a>Generated Summary: id: 12345689 (OFFICIAL); status: completed; intent: order; Nystatin 100,000 u/ml oral suspension; authoredOn: 2015-01-15</a></p></div>" }, "identifier": [ { "use": "official", "system": "http://www.bmc.nl/portal/prescriptions", "value": "12345689" } ], "status": "active", "intent": "order", "medicationCodeableConcept": { "coding": [ { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "code": "1313112", "display": "Phenytoin 25mg/ml oral suspension" } ] }, "subject": { "reference": "Patient/pat1", "display": "Donald Duck" }, "authoredOn": "2015-01-15", "requester": { "reference": "Practitioner/f007", "display": "Patrick Pump" }, "reasonCode": [ { "coding": [ { "system": "http://snomed.info/sct", "code": "230456007", "display": "Status epilepticus (disorder)" } ] } ], "note": [ { "text": "Patient should be counselled to ensure good dental hygiene" } ], "dosageInstruction": [ { "sequence": 1, "text": "100mg (4ml) three times daily", "timing": { "repeat": { "frequency": 3, "period": 1, "periodUnit": "d" } }, "route": { "coding": [ { "system": "http://snomed.info/sct", "code": "26643006", "display": "Oral Route (qualifier value)" } ] }, "doseAndRate": [ { "type": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/dose-rate-type", "code": "ordered", "display": "Ordered" } ] }, "doseQuantity": { "value": 100, "unit": "mg", "system": "http://unitsofmeasure.org", "code": "mg" } } ] } ], "dispenseRequest": { "validityPeriod": { "start": "2015-01-15", "end": "2016-01-15" }, "numberOfRepeatsAllowed": 3, "quantity": { "value": 360, "unit": "mL", "system": "http://unitsofmeasure.org", "code": "mL" }, "expectedSupplyDuration": { "value": 30, "unit": "days", "system": "http://unitsofmeasure.org", "code": "d" } }, "substitution": { "allowedBoolean": true, "reason": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ActReason", "code": "CT", "display": "Continuing therapy" } ] } }, "priorPrescription": { "reference": "MedicationRequest/medrx0304" } }
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.